In """"""""Novel biomarkers and Risk Prediction Modeling in RA"""""""" we propose to study metabolites and metabolic profiles as new biomarkers of RA risk. The hypothesis underlying this proposal is that concentrations of certain metabolites involving the activation of multiple enzymatic pathways are highly discriminatory for a population at high risk for developing RA. We have validated RA risk prediction models and demonstrated the improvement in accuracy with addition of genetic risk scores and gene-environment interactions to environmental factors. We have demonstrated associations for novel autoantibodies and cytokines with RA risk. Our team has expertise in epidemiology, genetics, predictive modeling, biomarker analysis, and network and pathway analysis.
Specific Aims are to: 1) identify individual metabolites and metabolic profiles associated with RA risk in both untargeted and candidate approaches with discovery analyses in the Nurses'Health Study cohorts and replication analyses in the Department of Defense military cohort;we will use advanced biostatistical techniques to identify novel RA risk metabolic patterns, as well as to investigate whether validated metabolic profiles, previously associated with the gastrointestinal microbiota and inflammation, atherosclerosis and cardiovascular disease are also associated with RA risk;2) examine whether intermediate biomarkers of RA (IL-6, TNFR2, MCP-1, anti-citrullinated protein antibodies) are associated with distinct metabolic profiles and whether biomarkers mediate the relationship of metabolites to RA risk;3) investigate whether relationships between both lifestyle factors and genetic risk scores and RA risk are mediated by individual metabolites and metabolic profiles. We will use our epidemiologic expertise to build comprehensive models that include environmental factors, cytokines, autoantibodies, metabolic profiles, and genetic predictors that can be used to identify high risk populations for targeted prevention therapy. The discovery of novel metabolic biomarkers associated with a greater likelihood of RA would provide an important public health benefit to subjects at high risk of RA due to family history and genetics.

Public Health Relevance

Changes in blood metabolites, such as sugars, amino acids, and lipids, have been linked to increased risk of several chronic diseases. Our goal is to comprehensively examine metabolites in the blood among people who later develop rheumatoid arthritis (RA), a disabling autoimmune disease of unknown cause, comparing them to people who do not develop RA. The discovery of novel metabolic biomarkers for RA risk would provide an important public health benefit to people at high risk of RA due to family history and genetics.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
2R01AR049880-11
Application #
8721627
Study Section
Neurological, Aging and Musculoskeletal Epidemiology Study Section (NAME)
Program Officer
Wang, Yan Z
Project Start
2003-09-01
Project End
2019-08-31
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
11
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02115
Ananthakrishnan, Ashwin N; Cagan, Andrew; Cai, Tianxi et al. (2016) Statin Use Is Associated With Reduced Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 14:973-9
Karlson, Elizabeth W; van Schaardenburg, Dirkjan; van der Helm-van Mil, Annette H (2016) Strategies to predict rheumatoid arthritis development in at-risk populations. Rheumatology (Oxford) 55:6-15
Prescott, Jennifer; Karlson, Elizabeth W; Orr, Esther H et al. (2016) A Prospective Study Investigating Prediagnostic Leukocyte Telomere Length and Risk of Developing Rheumatoid Arthritis in Women. J Rheumatol 43:282-8
Harris, Holly R; Costenbader, Karen H; Mu, Fan et al. (2016) Endometriosis and the risks of systemic lupus erythematosus and rheumatoid arthritis in the Nurses' Health Study II. Ann Rheum Dis 75:1279-84
Chang, Hui-Hsin; Liu, Guang-Yaw; Dwivedi, Nishant et al. (2016) A molecular signature of preclinical rheumatoid arthritis triggered by dysregulated PTPN22. JCI Insight 1:e90045
Tedeschi, Sara K; Costenbader, Karen H (2016) Is There a Role for Diet in the Therapy of Rheumatoid Arthritis? Curr Rheumatol Rep 18:23
Tedeschi, Sara K; Cui, Jing; Arkema, Elizabeth V et al. (2016) Elevated BMI and antibodies to citrullinated proteins interact to increase rheumatoid arthritis risk and shorten time to diagnosis: A nested case-control study of women in the Nurses' Health Studies. Semin Arthritis Rheum :
Lee, Yvonne C; Agnew-Blais, Jessica; Malspeis, Susan et al. (2016) Post-Traumatic Stress Disorder and Risk for Incident Rheumatoid Arthritis. Arthritis Care Res (Hoboken) 68:292-8
Ananthakrishnan, Ashwin N; Cagan, Andrew; Cai, Tianxi et al. (2016) Comparative Effectiveness of Infliximab and Adalimumab in Crohn's Disease and Ulcerative Colitis. Inflamm Bowel Dis 22:880-5
Sparks, Jeffrey A; Chang, Shun-Chiao; Liao, Katherine P et al. (2016) Rheumatoid Arthritis and Mortality Among Women During 36 Years of Prospective Follow-Up: Results From the Nurses' Health Study. Arthritis Care Res (Hoboken) 68:753-62

Showing the most recent 10 out of 112 publications